Edmond, OK, United States of America

Shrikant Anant


Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Edmond, OK (US) (2011 - 2012)
  • St. Louis, MO (US) (2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Shrikant Anant: Innovator in Cancer Detection and Treatment

Introduction

Shrikant Anant is a prominent inventor based in Edmond, OK (US). He has made significant contributions to the field of cancer research, particularly in the detection and treatment of cancer stem cells. With a total of 4 patents to his name, Anant's work is paving the way for advancements in oncology.

Latest Patents

Anant's latest patents include groundbreaking compositions useful for cancer detection and treatment. One of his notable inventions is a cancer stem cell model, which identifies DCAMKL-1 as a biomarker for both stem cells and cancer stem cells. His methods encompass detecting the presence of stem cells, isolating them, and inhibiting the growth of cancer cells utilizing DCAMKL-1. Additionally, he has developed siRNA-mediated inhibition techniques targeting doublecortin and Ca2+/calmodulin-dependent kinase-like-1, further enhancing the potential for cancer therapies.

Career Highlights

Anant is affiliated with the University of Oklahoma, where he conducts his research and develops innovative solutions for cancer treatment. His work has garnered attention for its potential impact on improving patient outcomes in oncology.

Collaborations

Some of his notable coworkers include Courtney W Houchen and Sripathi M Sureban, who contribute to the collaborative efforts in advancing cancer research.

Conclusion

Shrikant Anant's innovative work in cancer detection and treatment exemplifies the importance of research in the fight against cancer. His contributions are vital for the development of effective therapies and improving the lives of patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…